Accelerate Diagnostics Gross Margin 2010-2024 | AXDXQ
Current and historical gross margin for Accelerate Diagnostics (AXDXQ) over the last 10 years. The current gross profit margin for Accelerate Diagnostics as of December 31, 2024 is %.
| Accelerate Diagnostics Gross Margin Historical Data |
| Date |
TTM Revenue |
TTM Gross Profit |
Gross Margin |
| 2024-12-31 |
$0.01B |
$0.00B |
25.00% |
| 2024-09-30 |
$0.01B |
$0.00B |
33.33% |
| 2024-06-30 |
$0.01B |
$0.00B |
25.00% |
| 2024-03-31 |
$0.01B |
$0.00B |
25.00% |
| 2023-12-31 |
$0.01B |
$0.00B |
25.00% |
| 2023-09-30 |
$0.01B |
$0.00B |
25.00% |
| 2023-06-30 |
$0.01B |
$0.00B |
33.33% |
| 2023-03-31 |
$0.01B |
$0.00B |
30.77% |
| 2022-12-31 |
$0.01B |
$0.00B |
30.77% |
| 2022-09-30 |
$0.01B |
0 |
0.00% |
| 2022-06-30 |
$0.01B |
0 |
0.00% |
| 2022-03-31 |
$0.01B |
0 |
0.00% |
| 2021-12-31 |
$0.01B |
0 |
0.00% |
| 2021-09-30 |
$0.01B |
$0.00B |
33.33% |
| 2021-06-30 |
$0.01B |
$0.00B |
30.77% |
| 2021-03-31 |
$0.01B |
$0.00B |
33.33% |
| 2020-12-31 |
$0.01B |
$0.00B |
36.36% |
| 2020-09-30 |
$0.01B |
$0.01B |
45.45% |
| 2020-06-30 |
$0.01B |
$0.01B |
55.56% |
| 2020-03-31 |
$0.01B |
$0.01B |
55.56% |
| 2019-12-31 |
$0.01B |
$0.01B |
55.56% |
| 2019-09-30 |
$0.01B |
$0.00B |
50.00% |
| 2019-06-30 |
$0.01B |
$0.00B |
57.14% |
| 2019-03-31 |
$0.01B |
$0.00B |
57.14% |
| 2018-12-31 |
$0.01B |
$0.00B |
50.00% |
| 2018-09-30 |
$0.01B |
$0.00B |
50.00% |
| 2018-06-30 |
$0.01B |
$0.00B |
50.00% |
| 2018-03-31 |
$0.01B |
$0.00B |
60.00% |
| 2017-12-31 |
$0.01B |
$0.00B |
80.00% |
| 2017-09-30 |
$0.00B |
$0.00B |
100.00% |
| 2017-06-30 |
$0.00B |
$0.00B |
100.00% |
| 2017-03-31 |
$0.00B |
$0.00B |
100.00% |
| 2016-12-31 |
$0.00B |
0 |
0.00% |
| 2016-09-30 |
$0.00B |
0 |
0.00% |
| 2016-06-30 |
$0.00B |
0 |
0.00% |
| 2016-03-31 |
$0.00B |
0 |
0.00% |
| 2015-12-31 |
$0.00B |
0 |
0.00% |
| 2015-09-30 |
$0.00B |
0 |
0.00% |
| 2015-06-30 |
$0.00B |
0 |
0.00% |
| 2015-03-31 |
$0.00B |
0 |
0.00% |
| 2014-12-31 |
$0.00B |
0 |
0.00% |
| 2014-09-30 |
$0.00B |
0 |
0.00% |
| 2014-06-30 |
$0.00B |
0 |
0.00% |
| 2014-03-31 |
$0.00B |
0 |
0.00% |
| 2013-12-31 |
$0.00B |
0 |
0.00% |
| 2013-06-30 |
$0.00B |
0 |
0.00% |
| 2013-03-31 |
$0.00B |
0 |
0.00% |
| 2012-10-31 |
$0.00B |
0 |
0.00% |
| 2012-09-30 |
$0.00B |
0 |
0.00% |
| 2012-06-30 |
$0.00B |
0 |
0.00% |
| 2012-04-30 |
$0.00B |
0 |
0.00% |
| 2012-01-31 |
$0.00B |
0 |
0.00% |
| 2011-10-31 |
$0.00B |
0 |
0.00% |
| 2011-01-31 |
$0.00B |
0 |
0.00% |
| 2010-10-31 |
$0.00B |
0 |
0.00% |
| 2010-01-31 |
$0.00B |
0 |
0.00% |
| 2009-10-31 |
$0.00B |
0 |
0.00% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED INSTRUMENTS |
$0.001B |
$0.012B |
|
Accelerate Diagnostics, Inc. is focused on developing and commercializing instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The company is developing BACcel(TM) system, a rapid diagnostic platform for diagnosis in life-threatening bacterial infections and OptiChem(R) surface coatings for use in micro arraying components. Accelerate Diagnostics Inc., formerly known as Accelr8 Technology Corp., is based in Denver, Colorado.
|
